A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/22357883/ below:

Impact of mammography detection on the course of breast cancer in women aged 40-49 years

. 2012 Mar;262(3):797-806. doi: 10.1148/radiol.11111734. Impact of mammography detection on the course of breast cancer in women aged 40-49 years

Affiliations

Affiliation

Item in Clipboard

Impact of mammography detection on the course of breast cancer in women aged 40-49 years

Judith A Malmgren et al. Radiology. 2012 Mar.

. 2012 Mar;262(3):797-806. doi: 10.1148/radiol.11111734. Affiliation

Item in Clipboard

Abstract

Purpose: To analyze trends in detection method related to breast cancer stage at diagnosis, treatments, and outcomes over time among 40-49-year-old women.

Materials and methods: i This study was institutional review board approved, with a waiver of informed consent, and HIPAA compliant. A longitudinal prospective cohort study was conducted of women aged 40-49 years who had primary breast cancer, during 1990-2008, and were identified and tracked by a dedicated registry database (n = 1977). Method of detection--patient detected (PtD), physician detected (PhysD), or mammography detected (MamD)--was chart abstracted. Disease-specific survival and relapse-free survival statistics were calculated by using the Kaplan-Meier method for stage I-IV breast cancer.

Results: A significant increase in the percentage of MamD breast cancer over time (28%-58%) and a concurrent decline in patient and physician detected (Pt/PhysD) breast cancer (73%-42%) (Pearson x(2) = 72.72, P < .001) were observed over time from 1990 to 2008, with an overall increase in lower-stage disease detection and a decrease in higher-stage disease. MamD breast cancer patients were more likely to undergo lumpectomy (67% vs 48% of Pt/PhysD breast cancer patients) and less likely to undergo modified radical mastectomy (25% vs 47% of the Pt/PhysD breast cancer patients) (P < .001). Uncorrected for stage, 13% of MamD breast cancer patients underwent surgery and chemotherapy versus 22% of Pt/PhysD breast cancer patients (P < .001), and 31% of MamD breast cancer patients underwent surgery, radiation therapy, and chemotherapy versus 59% of Pt/PhysD breast cancer patients (x(2) = 305.13, P < .001). Analyzing invasive cancers only, 5-year relapse-free survival for MamD breast cancer patients was 92% versus 88% for Pt/PhysD patients (log-rank test, 12.47; P < .001).

Conclusion: Increased mammography-detected breast cancer over time coincided with lower-stage disease detection resulting in reduced treatment and lower rates of recurrence, adding factors to consider when evaluating the benefits of mammography screening of women aged 40-49 years.

© RSNA, 2012.

PubMed Disclaimer

Figures

Figure 1:

Flow diagram.

Figure 1:

Flow diagram.

Figure 1:

Flow diagram.

Figure 2:

Proportional change in detection method…

Figure 2:

Proportional change in detection method in women aged 40–49 years over time for…

Figure 2:

Proportional change in detection method in women aged 40–49 years over time for years 1990–2008 (n = 1977).

Figure 3:

Number of cases according to…

Figure 3:

Number of cases according to detection method in women aged 40–49 years over…

Figure 3:

Number of cases according to detection method in women aged 40–49 years over time for years 1990–2008 (n = 1977).

Figure 4:

Change in tumor stage for…

Figure 4:

Change in tumor stage for breast cancers diagnosed with all detection methods according…

Figure 4:

Change in tumor stage for breast cancers diagnosed with all detection methods according to year of diagnosis over time for years 1990–2008 (n = 1977).

Figure 5:

Change in tumor stage for…

Figure 5:

Change in tumor stage for MamD breast cancer cases according to year of…

Figure 5:

Change in tumor stage for MamD breast cancer cases according to year of diagnosis over time for years 1990–2008 (n = 865).

Figure 6:

Relapse-free survival after diagnosis according…

Figure 6:

Relapse-free survival after diagnosis according to detection method ( n = 1583).

Figure 6:

Relapse-free survival after diagnosis according to detection method (n = 1583).

Figure 7:

Disease-specific survival after diagnosis according…

Figure 7:

Disease-specific survival after diagnosis according to detection method ( n = 1610).

Figure 7:

Disease-specific survival after diagnosis according to detection method (n = 1610).

Figure 8:

Overall survival after diagnosis according…

Figure 8:

Overall survival after diagnosis according to detection method ( n = 1627).

Figure 8:

Overall survival after diagnosis according to detection method (n = 1627).

Similar articles Cited by References
    1. American Cancer Society Breast cancer facts and figures 2010. Atlanta, Ga: American Cancer Society, 2010.
    1. Altekruse SF, Kosary CL, Krapcho M, et al., eds. SEER cancer statistics review, 1975-2007, National Cancer Institute; Bethesda, Md: National Cancer Institute, 2010. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission. Published 2010. Accessed April 16, 2010.
    1. U.S. Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151(10):716–726. - PubMed
    1. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39:2772–2782. - PubMed
    1. Alexander FE, Anderson TJ, Brown HK, et al. . 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353(9168):1903–1908. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3